• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带状疱疹疫苗接种后血液中的水痘-带状疱疹病毒 DNA。

Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.

机构信息

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora.

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora.

出版信息

J Infect Dis. 2018 Mar 13;217(7):1055-1059. doi: 10.1093/infdis/jix653.

DOI:10.1093/infdis/jix653
PMID:29409017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5939641/
Abstract

We studied the relationship between varicella-zoster virus (VZV) DNAemia and development of VZV-specific immunity after administration of live-attenuated zoster vaccine. VZV-DNAemia, detected by polymerase chain reaction (PCR), and VZV-specific effector (Teff) and memory (Tmem) T cells, was measured in 67 vaccinees. PCR was positive in 56% (9 direct, 28 nested) on day 1 and in 16% (1 direct, 10 nested) on day 14. Teff progressively increased in direct-PCR-positive vaccinees up to day 30, but Tmem did not. Conversely, Tmem, but not Teff, increased in direct-PCR-negative vaccinees on day 7. The kinetics of these immune responses and VZV DNAemia suggested that direct-PCR sample positive represented viremia.

摘要

我们研究了水痘带状疱疹病毒 (VZV) DNA 血症与活减毒带状疱疹疫苗接种后 VZV 特异性免疫的发展之间的关系。通过聚合酶链反应 (PCR) 检测 VZV-DNA 血症,并测量 67 名疫苗接种者中的 VZV 特异性效应 (Teff) 和记忆 (Tmem) T 细胞。在第 1 天,PCR 阳性率为 56%(9 个直接检测,28 个巢式检测),在第 14 天为 16%(1 个直接检测,10 个巢式检测)。在直接 PCR 阳性的疫苗接种者中,Teff 逐渐增加,直到第 30 天,但 Tmem 没有增加。相反,在直接 PCR 阴性的疫苗接种者中,Tmem 在第 7 天增加,而 Teff 没有增加。这些免疫反应和 VZV DNA 血症的动力学表明,直接 PCR 样本阳性代表病毒血症。

相似文献

1
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.带状疱疹疫苗接种后血液中的水痘-带状疱疹病毒 DNA。
J Infect Dis. 2018 Mar 13;217(7):1055-1059. doi: 10.1093/infdis/jix653.
2
The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.年龄对带状疱疹活疫苗免疫原性的影响可通过基线调节性 T 细胞和水痘-带状疱疹病毒特异性 T 细胞免疫来预测。
J Virol. 2019 Jul 17;93(15). doi: 10.1128/JVI.00305-19. Print 2019 Aug 1.
3
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.带状疱疹疫苗老年接种者中的水痘-带状疱疹病毒特异性免疫反应。
J Infect Dis. 2008 Mar 15;197(6):825-35. doi: 10.1086/528696.
4
Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.比较活疫苗和重组带状疱疹疫苗的抗体反应。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00240-21.
5
Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.水痘带状疱疹病毒糖蛋白特异性抗体的广度和功能在人类接种 Zostavax 后得到鉴定。
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00269-18. Print 2018 Jul 15.
6
Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.接种水痘带状疱疹病毒疫苗后,成人骨髓中水痘带状疱疹病毒特异性浆细胞的持续存在。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.02127-19.
7
Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.一项随机对照试验的方案,该试验旨在表征肯尼亚健康女性接种水痘带状疱疹病毒(VZV)疫苗所诱导的免疫反应:为潜在的基于VZV的HIV疫苗奠定基础。
BMJ Open. 2017 Sep 21;7(9):e017391. doi: 10.1136/bmjopen-2017-017391.
8
Zoster vaccine: current status and future prospects.带状疱疹疫苗:现状与未来前景。
Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605.
9
Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.带状疱疹疫苗可增加对水痘带状疱疹病毒产生反应的CD4 + T细胞的广度。
J Infect Dis. 2015 Oct 1;212(7):1022-31. doi: 10.1093/infdis/jiv164. Epub 2015 Mar 17.
10
Th1 memory differentiates recombinant from live herpes zoster vaccines.Th1 记忆区分重组与活带状疱疹疫苗。
J Clin Invest. 2018 Oct 1;128(10):4429-4440. doi: 10.1172/JCI121484. Epub 2018 Jul 19.

引用本文的文献

1
Coagulation functions and factors correlated with central nervous system infection in herpes zoster patients.带状疱疹患者凝血功能及相关因子与中枢神经系统感染的相关性
Front Immunol. 2025 May 9;16:1511901. doi: 10.3389/fimmu.2025.1511901. eCollection 2025.
2
Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination.对带状疱疹活疫苗接种后严重不良事件发生过程中病理机制的见解。
J Virol. 2025 Feb 25;99(2):e0181624. doi: 10.1128/jvi.01816-24. Epub 2025 Jan 17.
3
Serious neurological adverse events in immunocompetent children and adolescents caused by viral reactivation in the years following varicella vaccination.水痘疫苗接种后数年免疫功能正常的儿童和青少年因病毒再激活引起的严重神经系统不良事件。
Rev Med Virol. 2024 May;34(3):e2538. doi: 10.1002/rmv.2538.
4
Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.聚乳酸-共乙醇酸纳米粒子与核酸佐剂联合包载水痘-带状疱疹病毒糖蛋白 E 诱导小鼠产生的免疫应答
Virol Sin. 2021 Feb;36(1):122-132. doi: 10.1007/s12250-020-00261-y. Epub 2020 Aug 5.
5
Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.接受有效抗逆转录病毒治疗的HIV感染者带状疱疹的免疫相关性
AIDS Res Hum Retroviruses. 2019 Oct;35(10):890-895. doi: 10.1089/AID.2019.0053. Epub 2019 Jul 16.
6
Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.水痘带状疱疹病毒活疫苗不会诱导 HIV 靶细胞激活。
J Clin Invest. 2019 Feb 1;129(2):875-886. doi: 10.1172/JCI124473. Epub 2019 Jan 22.
7
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.接受免疫抑制治疗的免疫介导性疾病患者的疫苗接种指南
J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.
8
Th1 memory differentiates recombinant from live herpes zoster vaccines.Th1 记忆区分重组与活带状疱疹疫苗。
J Clin Invest. 2018 Oct 1;128(10):4429-4440. doi: 10.1172/JCI121484. Epub 2018 Jul 19.

本文引用的文献

1
Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.年轻人和老年人对减毒活带状疱疹疫苗的水痘-带状疱疹病毒特异性细胞免疫反应
J Immunol. 2017 Jul 15;199(2):604-612. doi: 10.4049/jimmunol.1700290. Epub 2017 Jun 12.
2
Metabolic Phenotypes of Response to Vaccination in Humans.人类接种疫苗反应的代谢表型
Cell. 2017 May 18;169(5):862-877.e17. doi: 10.1016/j.cell.2017.04.026. Epub 2017 May 11.
3
Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.水痘-带状疱疹病毒及其病毒 DNA 存在于潜伏性或活动性水痘-带状疱疹病毒感染者的血液和咽峡部。
J Clin Virol. 2014 Dec;61(4):487-95. doi: 10.1016/j.jcv.2014.09.012. Epub 2014 Oct 2.
4
Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine.在接种带状疱疹疫苗的免疫功能正常受种者中,由疫苗株水痘-带状疱疹病毒引起的带状疱疹
Clin Infect Dis. 2014 Apr;58(8):1125-8. doi: 10.1093/cid/ciu058. Epub 2014 Jan 26.
5
Persistence of varicella zoster virus DNA in saliva after herpes zoster.带状疱疹后唾液中单纯疱疹病毒 DNA 的持续存在。
J Infect Dis. 2011 Sep 15;204(6):820-4. doi: 10.1093/infdis/jir425.
6
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization.水痘-带状疱疹病毒 DNA 在接种部位和接种 Zostavax 疫苗后唾液中的存在。
J Infect Dis. 2011 Jun 1;203(11):1542-5. doi: 10.1093/infdis/jir139.
7
Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.年龄和原发感染性质对水痘-带状疱疹病毒特异性细胞免疫应答的影响。
J Infect Dis. 2010 Apr 1;201(7):1024-30. doi: 10.1086/651199.
8
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.在一项临床有效的带状疱疹疫苗试验中,老年参与者对带状疱疹的水痘-带状疱疹病毒特异性免疫反应。
J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.
9
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).带状疱疹的预防:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.
10
Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia.从人三叉神经节分离出的细胞中的水痘带状疱疹病毒DNA。
J Virol. 2003 Jun;77(12):6979-87. doi: 10.1128/jvi.77.12.6979-6987.2003.